Cholesterol-dependent cytolysins are a family of pore-forming proteins that have been shown to be virulence factors for a large number of pathogenic bacteria. The mechanism of pore formation for these toxins involves a complex series of events that are known to include binding, oligomerization, and insertion of a transmembrane β-barrel. Several features of this mechanism remain poorly understood and controversial.
INTRODUCTION
Cholesterol-dependent cytolysins (CDCs) 1 are produced by a variety of pathogenic Gram positive bacteria (reviewed in 1,2). The monomeric forms of the CDCs are highly water-soluble, but the proteins bind to cholesterol-containing membranes and then spontaneously self-associate to form large aqueous pores in the bilayer. These oligomeric complexes vary in size and may contain up to 50 individual monomers (3) (4) (5) .
The only crystal structure of a water-soluble, monomeric form of a CDC was solved by Rossjohn et al (6) for perfringolysin O (PFO) from Clostridium perfringens, and their data revealed that PFO is comprised of four domains. The crystal structure of a membrane-inserted oligomer of a CDC is not presently available. However, several fluorescence-based studies have identified the regions of PFO that form a transmembrane β-barrel, and have also provided other structural information about the membrane-inserted oligomer. Domain 3 of PFO contains two stretches of amino acids (190-217 and 288-311) that interact with the membrane during pore formation and create an amphipathic β-sheet that serves as an aqueous-lipid interface after insertion into the membrane (7, 8) . Domain 4 (residues 391-500) is involved in membrane recognition and binding, and remains close to the membrane surface in the membraneinserted oligomer where it contacts, but is not deeply embedded in, the bilayer (9,10).
The mechanism of action of the CDCs involves a complex series of events that are known to include the binding and stable association with cholesterol-containing 4
The relative timing of oligomer formation and of the insertion of individual transmembrane β-hairpins (TMHs) has been a subject of controversy (1, 2, 20, 21) . Two different models have been proposed to explain the insertion of the CDC β-sheet into the membrane, one based on the prepore mechanism that has been shown to mediate the formation of small pores by several toxins ( Fig. 1A ; [22] [23] [24] [25] , and the other on the gradual enlargement of a small oligomer and pore into a large oligomer and pore by the sequential addition of monomers to an initial inserted complex ( Fig. 1B; 15 ).
Shepard et al (16) showed that a PFO oligomeric complex is formed on liposomes at both 4 o C and 37 o C, and also showed by SDS-agarose electrophoresis that this oligomer is large and relatively uniform in size. At low temperatures, these authors were able to identify the formation of a prepore complex formed in the absence of significant insertion of the TMHs. Furthermore, they showed that PFO was found to increase the ion conductivity through a planar bilayer by large and discrete stepwise changes in conductance that are consistent with the insertion of a preassembled pore complex into the bilayer. In contrast, Palmer et al (15) proposed that individual SLO monomers are inserted and added to the pre-existing oligomers on erythrocyte membranes to produce a pore that grows in size continuously until it reaches its final state.
To establish unambiguously whether PFO and SLO only form pores of a discrete, large size or, alternatively, pores whose diameter is continually increasing, we have analyzed the mechanism of pore formation using fluorophores of different sizes to monitor pore dimensions. Several fluorescein-labeled peptides and proteins with different hydrodynamic radii were encapsulated into cholesterol-containing liposomes, and the kinetics of pore formation was detected by the rate of fluorophore exposure to all sizes of trapped molecules should be released at the same time from the liposomes.
On the contrary, if the pore starts small and grows continuously, the smaller trapped molecules should be released faster than the larger ones.
As we have pointed out (10), major conformational changes in the elongated monomeric PFO structure (6) (9, 17) .
Are its TMHs lying on the surface of the membrane prior to the cooperative insertion of the TMHs to form the β-barrel (19)? If so, have the nonpolar sides of the hairpins already been exposed to the hydrophobic core of the bilayer? Does domain 4 sit on the membrane surface with the same orientation that it has in the membrane-inserted oligomer? Because so little is known about the prepore structure, we have also addressed the above important questions.
Fluorescence quenching analyses of the mechanism of pore formation for a functional PFO molecule reveal that: (i) the insertion of the oligomeric transmembrane β-barrel for PFO requires the formation of a prepore complex; (ii) neither PFO nor SLO are able to form small pores on cholesterol-containing membranes; and (iii) the interaction of PFO with the bilayer during binding and prepore assembly does not result in small molecule leakage through the membrane. In addition, the topographical examination of the prepore complex reveals that only the tip of domain 4 is embedded in the membrane bilayer, a topography similar to that observed in the final membraneinserted oligomer. In contrast, the domain 3 TMHs are not exposed to the nonpolar interior of the membrane in the prepore complex.
EXPERIMENTAL PROCEDURES
Preparation of Toxins Derivatives -The gene for PFO C459A , the cysteine-less derivative of PFO in which C459 was replaced by alanine, was cloned in pTrcHisA (Invitrogen, Carlsbad, CA) as described previously (7). This plasmid (named pRT20) was used as the template for all cysteine-substitution mutagenesis. The generation of cysteine-substituted derivatives of PFO C459A , their expression, and their purification have been described previously (7) . Single-cysteine mutants of PFO were 90-100% labeled with NBD and purified as before (7) . The toxin concentration was calculated using a molar absorptivity (ε) at 280 nm of 84,000 cm -1 M -1 for PFO (7) and of 71,300 cm -1 M -1 for SLO (26) .
Peptide and Protein Labeling with FITC -The labeling of carbonic anhydrase from bovine erythrocytes (CA), β-amylase from sweet potato (Amy), and thyroglobulin from bovine thyroid (Thy) (all from Sigma, St. Louis, MO) with fluorescein isothiocyanate isomer I (FITC, Molecular Probes, Eugene, OR) was performed as described by Heuck and Wolosiuk (27) . Briefly, the proteins (10 mg/ml) were incubated with FITC (molar ratio 1:2, protein:FITC) in 50 mM NaHCO 3 (pH 9.0) for 12 hr at room temperature with gentle mixing. measurements were performed at low temperature, the cuvette chamber was continuously flushed with N 2 to prevent condensation of water on the cuvettes. Kinetics measurements were done using 1 cm x 1 cm quartz cells and the samples were continuously stirred using a magnetic stirring bar (1.5 mm x 8 mm). End-point measurements were done in 4 mm x 4 mm quartz microcells that were coated with POPC vesicles to minimize protein adsorption (29) . When additions were made to microcells, the contents were mixed thoroughly with a 2 mm x 2 mm magnetic stirring bar as described previously (30) .
Time-Dependent Detection of PFO NBD or Trp Emission -A sample containing the
water-soluble PFO monomer (final concentration 25-100 nM) in buffer A was placed in the temperature-controlled cuvette chamber and measurements were taken until a stable signal was obtained (F 0 ). The kinetic analysis was started by the addition of liposomes (final concentration 50-100 µM in buffer A, final volume 1.6 ml), and data acquisition was initiated 15 sec later, after complete mixing of the sample. Emission intensities were recorded at the appropriate intervals and at least sixty measurements were taken for each experiment. Blank measurements were made using an otherwise identical sample that lacked the fluorophore. The blank data were subtracted from the corresponding sample data, and the net F 0 value was then dilution-corrected. Unless indicated, data collection and analysis were performed as described above. Staphylococcus aureus α-hemolysin (αHL) is a β-barrel pore-forming toxin that forms a transmembrane pore that is ~16 ∆ in diameter (24) . When liposomes encapsulating fluorescent molecules of different sizes were incubated with αHL, only the small fluorophores with a diameter of about 10 ∆ were able to pass through the αHL pore and be quenched ( Fig. 2A , Table I) . A large molecule like Amy-Fl (~100 ∆ in diameter) was unable to pass through the αHL transmembrane pore.
RESULTS

Determining the Size of Pores in Liposomal Membranes
To confirm that the observed fluorescence quenching was dictated by the size of the pore, and not by the nature of the fluorophore-quencher pair used in the assay, liposomes containing both a small fluorophore [Tb(DPA) 3 3-] and a large fluorescent molecule (Amy-Fl) were incubated with αHL (Fig. 2B) . The fast quenching of the emission intensity of Tb(DPA) 3 3-after addition of αHL clearly shows that the integrity of the membrane has been disrupted by the formation of pores that are at least 10 ∆ in diameter (the diameter of the pore required for the mixing of encapsulated Tb(DPA) 3 3- and extraliposomal EDTA). In contrast, Amy-Fl was not quenched because the fluorescent molecule and its quencher (the anti-fluorescein antibody) are too big to pass through the αHL pore. Thus, the emission intensity of fluorescein was unaffected by αHL addition. However, when PFO (pore diameter ~250 ∆) was added to the same sample, efficient quenching of Amy-Fl intensity was observed.
This fluorescence approach therefore not only allows direct detection of the formation of a transmembrane pore, but it also permits a direct estimation of the diameter of the newly-formed pore. Hence, this spectroscopic assay is both efficient and informative.
PFO Pore Formation: a Growing Pore or a Prepore Complex
Assembly? -Using the fluorescence approach described above, we can analyze pore-formation directly using a functional toxin and discriminate between the two models of pore formation proposed for the CDCs. If, as suggested by Palmer et al (15) , the toxin initially forms a small pore that is gradually enlarged during oligomerization, a small encapsulated fluorophore will be released from the liposome before a large fluorophore. Therefore, immediately following addition of the toxin, the rate of fluorescence quenching should be faster for small fluorophores than for larger fluorophores. In contrast, if a prepore complex must be completely formed (i.e., a complete ring) before the insertion of the TMHs, any pores that are formed will have a diameter of ~250 Å, and hence both large 13 and small fluorophores would be released from the liposome and quenched at the same rate (ignoring small differences due to different rates of diffusion).
To distinguish between these two possibilities, we encapsulated fluoresceinlabeled peptides and proteins of different molecular sizes into liposomes (Table I) Comparing PFO and SLO -As mentioned above, it has been suggested that SLO forms a pore that gradually grows in size, concomitantly with the oligomerization of the toxin (15; Fig. 1B ). Based on the above results obtained for PFO, this would imply that CDCs do not use a common mechanism of pore formation. The primary sequences of PFO and SLO are 65% identical, and both structural and mechanistic similarities between the proteins have been reported (7) (8) (9) 18, 34) . Although it seems unlikely that the PFO and SLO homologues would insert into the bilayer via vastly different mechanisms, the two toxins have to be examined in parallel using the same experimental approach to assess the extent of similarity in their mechanism of pore formation.
In doing a comparative analysis of the release of different-sized markers from liposomes, one must be sensitive to the relative concentration of toxins and liposomes.
For example, if both a small and a large marker are incorporated into the same liposomal preparation, and the liposomes are incubated with PFO, the emission intensity of both markers will be strongly quenched at high toxin/lipid molar ratio (i.e., at conditions where the formation of complete rings is favored). But at a low toxin/lipid ratio, the quenching of the markers will diminish, and will be limited by the rare event of binding of sufficient monomers on an individual liposome to form a pore. Nevertheless, independent of the total number of pores formed, the extents of quenching for the different markers should be identical if only large pores are formed.
In contrast, if only a few toxin molecules are able to form a pore (as suggested for SLO; 15), the pattern of fluorescence intensity quenching will be very different. The extent of quenching of the large marker will parallel the extent of quenching of the small marker only at high toxin/lipid ratio (note: the rates would still differ). At low toxin/lipid ratio, where only a few monomers will distribute, on average, on each liposome, the extent of quenching of the small marker is expected to be higher than that of the large one.
Using liposomes containing both a large marker (Amy-Fl) and a small marker [Tb(DPA) 3 3-], we quantified the total release of each fluorophore after incubating a set amount of liposomes with increasing amounts of PFO and SLO. Serial 1:2 dilutions of the toxins were prepared and an identical volume of each toxin solution was added to samples containing identical total lipid concentrations. As shown in Fig. 4A , the percentage of release for both large and small markers was very similar at every toxin/lipid ratio, thereby indicating that PFO is not able to form small pores on cholesterol-containing membranes. The quenching pattern obtained for SLO (Fig. 4B) was very similar to that obtained for PFO, indicating that SLO also cannot form small pores in the liposomal membrane. Therefore, we conclude that pore formation by SLO also requires the formation of a prepore complex.
Characterization of the PFO Prepore Complex -PFO pore formation can be halted at the prepore complex stage prior to TMH insertion into the bilayer by engineering a disulfide bond that prevents TMH extension (9, 17) , by mutation that prevents TMH insertion (19) , or by incubation with membranes at low temperatures (16) . One advantage of the last method of creating a prepore intermediate is that we can use a functional toxin instead of an inactive mutant.
The temperature-dependent interactions of domain 4 and of the domain 3 TMHs with membranes were analyzed using liposomes containing spin-labeled phospholipids.
Intrinsic tryptophan fluorescence was monitored to follow the interaction of domain 4 with the membrane (9, 35, 36) , while extrinsic NBD fluorescence was monitored to detect the interaction of a TMH with the bilayer (7-9). Since excited NBD and Trp moieties lose their excited state energy if they contact a nitroxide moiety, the emission intensity of the sample will be reduced if a Trp or NBD fluorophore is embedded in the bilayer where it can collide with the nitroxide moiety on a spin-labeled phospholipid (33, 37) . Since no fluorescence change will be observed if the collisional quencher and the Trp or NBD do not contact each other, this approach directly measures the accessibility of fluorescent probe to quencher, and hence provides topographical information.
The tryptophan emission intensity increased when PFO was incubated with liposomes prepared without or with spin-labeled phospholipids as shown in Fig. 5A . In each case, tryptophan emission intensity increased to a maximum by 60 min at 2°C.
However, the magnitude of the final tryptophan emission intensity depended upon the location of the nitroxide quenchers, and hence the extent of collisional quenching in the liposomes. Thus, in the prepore complex the tryptophans in domain 4 are exposed to the bilayer interior, but are positioned close to the membrane surface, just as they are after pore formation has been completed (10).
In contrast, the emission intensity of an NBD probe located close to the tip of the TMH2 hairpin (PFO I303C-NBD ; 8) was unaltered by prepore formation. Although the NBD emission intensity of this PFO mutant increases substantially when TMH2 is embedded in the interior of the bilayer (8) , no increase in intensity was observed at low temperature even after 80 min (Fig. 5B) . Consistent with the absence of any indication that this NBD was exposed to the bilayer core in the prepore complex, no nitroxide dependent quenching of NBD intensity was observed (circles) unless the sample is incubated at 37 o C (squares). Similar results were obtained when the probe was located at different locations on TMH1 and TMH2 (Table II) . [Even though the F/F 0 value for the PFO T301C-NBD derivative at 2 o C was 2.8, the NBD moiety is not exposed to the lipid bilayer because the dye was not quenched when 5-doxyl-PC was incorporated into the liposomal membrane (data not shown)]. Thus, we conclude that the TMHs located in domain 3 are not exposed to the membrane interior in the prepore complex.
Does the Interaction of Domain 4 with the Bilayer Affect the Permeability of the
Liposomal Membranes? -The mechanism by which lipids are ultimately eliminated from an aqueous CDC pore remains one of the most obscure aspects of pore formation. As do not alter the permeability of the bilayer. Moreover, the absence of pore formation at low temperature confirms our previous results that showed that the domain 4-membrane interaction can be uncoupled from the insertion of the TMHs (9). Thus, under conditions where the insertion of the TMHs is prevented (9, 16, 19) , PFO is able to bind to the membrane, oligomerize, and form a prepore complex without disrupting the membrane sufficiently to cause a significant leakage of the liposomal contents.
DISCUSSION
Our spectroscopic examination has provided five important insights into the mechanism of CDC pore formation. It has been shown recently that PFO can form a prepore complex on the membrane prior to the insertion of the transmembrane β-barrel. However, the presence of a stable prepore complex was only observed under conditions where the insertion of the β-hairpins was impeded (i.e., using non-pore-forming mutants, disulfide-trapped derivatives, or working at low temperatures; 9, 16, 17, 19) . Therefore, we could not rule out that under conditions where pore formation occurs (e.g., with the wild-type toxin at temperatures higher than 20 o C), the individual β-hairpins of PFO could insert into the membrane concomitantly with the oligomerization process as suggested in the growingpore model (15, Fig. 1B ).
To experimentally address this model and the alternative prepore model ( was identical for all of these fluorescent markers (Fig. 3) . Since the rate-limiting step of pore formation is oligomerization (9, 17) , these results clearly show that PFO C459A also forms a prepore complex, as has been previously shown for several non-pore-forming PFO mutants (16, 17, 19) . This prepore complex formation is then followed by the insertion of the β-barrel, which simultaneously allows all of the different-sized fluorophores to pass through the membrane.
Homologous CDCs Use a Similar Mechanism for Pore Formation -We have here
shown that the pore formation by PFO conforms to the prepore model (Fig. 1A) rather than the growing-pore model (Fig. 1B) . Palmer et al (15) used a similar approach to conclude that SLO pore formation proceeds via the growing pore model. In their study, rhodamine-labeled dextrans of different sizes were encapsulated into erythrocyte ghosts and the extents of fluorophore release (the kinetics were not measured) differed
for the large and the small dextrans. Do PFO and SLO use different mechanisms of pore formation, or are the observed differences caused by the different experimental procedures used? To resolve the discrepancy, we have examined PFO and SLO in parallel using the same experimental conditions.
Using liposomes that contained both small and large fluorophores, we analyzed the pattern of their release at different toxin/lipid molar ratios for both PFO and SLO.
The quenching results that we obtained clearly show that neither PFO nor SLO is able to form small pores on cholesterol-containing membranes (Fig. 4) . After the addition of PFO or SLO, the extents of release of large and small markers were very similar, thereby indicating that neither PFO nor SLO is able to form pores when only a few monomers are bound to each liposome. These similarities in the results indicate strongly that SLO also forms a prepore complex before inserting its TMHs to form the transmembrane β-barrel. Hence, we conclude that the homologous CDCs use a common insertion mechanism to form a transmembrane pore.
The reason for the discrepancy between our results and those of Palmer et al (15) is not known. However, since dextrans are known to bind to erythrocytes (e.g., 39), it is possible that the different extents of dextran release into the supernatant may reflect their differing affinities for the erythrocyte ghosts. The higher affinity (40) and larger number of adsorption sites of the larger dextran would then explain its delayed and reduced release from the ghosts. An alternative possibility is that the presence of proteins in the erythrocyte membrane may cause cytolysins to form an incomplete prepore complex and the subsequent formation of a pore significantly smaller in size than the one observed in liposomal membranes.
In the Prepore Complex, Domain 4 Sits on the Membrane Surface and the TMHs
Are remains on the membrane surface throughout the entire process of oligomerization, with only its tip embedded in the bilayer (Fig. 5A) . Thus, in the prepore complex, the relative orientation of domain 4 to the membrane surface is very similar to the one observed in the membrane-inserted oligomer (9).
In contrast, a similar analysis performed using several NBD-labeled mutants on TMH1 and TMH2 (7, 8) revealed that the NBD dyes located in either of these TMHs are not exposed to the membrane core either after binding to the membrane or after formation of the prepore complex (Fig. 5B , Table II ).
Formation of the Prepore Complex Does Not Disrupt the Membrane Permeability
Barrier -CDCs form large pores in cellular membranes that are big enough to allow the passage of large molecules (41) . Moreover, we have shown that the insertion of PFO TMHs into the bilayer correlates with the formation of those large pores (9,19; Fig. 3 and 4). It has also been suggested that the superficial interaction of a CDC with the bilayer may alter the structure of the membrane and allow small molecules and ions to permeate through the bilayer (38).
To examine this possibility, we tested the ability of PFO C459A to disrupt cholesterol- 
